Open AccessPhase II Study Suggests Tazemetostat Beneficial in Relapsed/Refractory
Publication year - 2017
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000527124.60627.eb
Subject(s) - refractory (planetary science) , medicine , pharmacology , phases of clinical research , oncology , intensive care medicine , clinical trial , biology , astrobiology